Please login to the form below
morning brief
This page shows the latest morning brief news and features for those working in and with pharma, biotech and healthcare.
Morning brief: New biotech launched, Merck and Moderna expand collaboration and more
A rapid round up of pharma, biotech and healthcare news
Latest news
-
Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more
A rapid round-up of pharma, biotech and healthcare news
-
Morning brief: CAR-T competition hots up, Keytruda sales soar and more
A rapid round-up of pharma, biotech and healthcare news
-
Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more
A rapid round up of pharma, biotech and healthcare news
-
Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more
A rapid run-down of news in pharma, biotech and healthcare
-
Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more
Sanofi falling behind in Amgen cholesterol battle. First quarter results from Sanofi show the company has got off to shaky start in 2018, including signs that it its PCKS9 inhibitor cholesterol treatment Praluent is falling behind Amgen’s rival
More from news
Approximately 3 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
